Does the media prefer AIRS or PSNL?

In the previous week, Personalis had 1 more articles in the media than AirSculpt Technologies. MarketBeat recorded 6 mentions for Personalis and 5 mentions for AirSculpt Technologies. AirSculpt Technologies' average media sentiment score of 0.40 beat Personalis' score of 0.30 indicating that AirSculpt Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AirSculpt Technologies 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Personalis 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to AIRS or OMDA?

In the previous week, AirSculpt Technologies had 1 more articles in the media than Omada Health. MarketBeat recorded 5 mentions for AirSculpt Technologies and 4 mentions for Omada Health. Omada Health's average media sentiment score of 1.24 beat AirSculpt Technologies' score of 0.40 indicating that Omada Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AirSculpt Technologies 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Omada Health 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer AIRS or LMRI?

In the previous week, AirSculpt Technologies had 1 more articles in the media than Lumexa Imaging. MarketBeat recorded 5 mentions for AirSculpt Technologies and 4 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 0.46 beat AirSculpt Technologies' score of 0.40 indicating that Lumexa Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AirSculpt Technologies 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lumexa Imaging 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer AIRS or TALK?

In the previous week, AirSculpt Technologies and AirSculpt Technologies both had 5 articles in the media. Talkspace's average media sentiment score of 1.50 beat AirSculpt Technologies' score of 0.40 indicating that Talkspace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AirSculpt Technologies 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Talkspace 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor CSTL or AIRS?

In the previous week, Castle Biosciences had 15 more articles in the media than AirSculpt Technologies. MarketBeat recorded 20 mentions for Castle Biosciences and 5 mentions for AirSculpt Technologies. Castle Biosciences' average media sentiment score of 0.46 beat AirSculpt Technologies' score of 0.40 indicating that Castle Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Castle Biosciences 8 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral AirSculpt Technologies 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

AirSculpt Technologies (AIRS) Competitors

$4.88 +0.07 (+1.46%)

Closing price 08/3/2026 04:00 PM Eastern

Extended Trading

$4.88 0.00 (0.00%)

As of 08/3/2026 07:34 PM Eastern

Compare

AIRS vs. PSNL, OMDA, LMRI, TALK, and CSTL

Should you buy AirSculpt Technologies stock or one of its competitors? MarketBeat compares AirSculpt Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with AirSculpt Technologies include Personalis (PSNL), Omada Health (OMDA), Lumexa Imaging (LMRI), Talkspace (TALK), and Castle Biosciences (CSTL).

How does AirSculpt Technologies compare to Personalis?

AirSculpt Technologies (NASDAQ:AIRS) and Personalis (NASDAQ:PSNL) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends.

In the previous week, Personalis had 1 more articles in the media than AirSculpt Technologies. MarketBeat recorded 6 mentions for Personalis and 5 mentions for AirSculpt Technologies. AirSculpt Technologies' average media sentiment score of 0.40 beat Personalis' score of 0.30 indicating that AirSculpt Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AirSculpt Technologies	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Personalis	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

AirSculpt Technologies has higher revenue and earnings than Personalis. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Personalis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AirSculpt Technologies	$151.82M	2.27	-$11.67M	-$0.17	N/A
Personalis	$69.65M	19.85	-$81.27M	-$1.02	N/A

AirSculpt Technologies has a beta of 2.33, meaning that its share price is 133% more volatile than the broader market. Comparatively, Personalis has a beta of 2.27, meaning that its share price is 127% more volatile than the broader market.

AirSculpt Technologies has a net margin of -7.39% compared to Personalis' net margin of -148.11%. AirSculpt Technologies' return on equity of -4.98% beat Personalis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AirSculpt Technologies	-7.39%	-4.98%	-2.36%
Personalis	-148.11%	-43.52%	-32.92%

AirSculpt Technologies currently has a consensus price target of $4.50, indicating a potential downside of 7.79%. Personalis has a consensus price target of $14.25, indicating a potential upside of 7.95%. Given Personalis' stronger consensus rating and higher probable upside, analysts plainly believe Personalis is more favorable than AirSculpt Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AirSculpt Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Personalis	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

91.5% of AirSculpt Technologies shares are held by institutional investors. Comparatively, 61.9% of Personalis shares are held by institutional investors. 44.6% of AirSculpt Technologies shares are held by company insiders. Comparatively, 4.2% of Personalis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

AirSculpt Technologies beats Personalis on 10 of the 16 factors compared between the two stocks.

How does AirSculpt Technologies compare to Omada Health?

AirSculpt Technologies (NASDAQ:AIRS) and Omada Health (NASDAQ:OMDA) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations.

In the previous week, AirSculpt Technologies had 1 more articles in the media than Omada Health. MarketBeat recorded 5 mentions for AirSculpt Technologies and 4 mentions for Omada Health. Omada Health's average media sentiment score of 1.24 beat AirSculpt Technologies' score of 0.40 indicating that Omada Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AirSculpt Technologies	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Omada Health	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AirSculpt Technologies has a beta of 2.33, indicating that its share price is 133% more volatile than the broader market. Comparatively, Omada Health has a beta of 1.73, indicating that its share price is 73% more volatile than the broader market.

AirSculpt Technologies currently has a consensus target price of $4.50, suggesting a potential downside of 7.79%. Omada Health has a consensus target price of $24.75, suggesting a potential upside of 20.67%. Given Omada Health's stronger consensus rating and higher probable upside, analysts clearly believe Omada Health is more favorable than AirSculpt Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AirSculpt Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Omada Health	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.71

AirSculpt Technologies has higher earnings, but lower revenue than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than AirSculpt Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AirSculpt Technologies	$151.82M	2.27	-$11.67M	-$0.17	N/A
Omada Health	$260.21M	4.69	-$12.78M	-$0.27	N/A

Omada Health has a net margin of -2.22% compared to AirSculpt Technologies' net margin of -7.39%. Omada Health's return on equity of -1.82% beat AirSculpt Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AirSculpt Technologies	-7.39%	-4.98%	-2.36%
Omada Health	-2.22%	-1.82%	-1.36%

91.5% of AirSculpt Technologies shares are held by institutional investors. 44.6% of AirSculpt Technologies shares are held by company insiders. Comparatively, 6.4% of Omada Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Omada Health beats AirSculpt Technologies on 9 of the 16 factors compared between the two stocks.

How does AirSculpt Technologies compare to Lumexa Imaging?

AirSculpt Technologies (NASDAQ:AIRS) and Lumexa Imaging (NASDAQ:LMRI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, dividends and analyst recommendations.

AirSculpt Technologies has higher earnings, but lower revenue than Lumexa Imaging. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Lumexa Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AirSculpt Technologies	$151.82M	2.27	-$11.67M	-$0.17	N/A
Lumexa Imaging	$267.73M	4.04	-$47.10M	-$0.59	N/A

Lumexa Imaging has a net margin of 0.00% compared to AirSculpt Technologies' net margin of -7.39%. Lumexa Imaging's return on equity of 0.00% beat AirSculpt Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AirSculpt Technologies	-7.39%	-4.98%	-2.36%
Lumexa Imaging	N/A	N/A	N/A

91.5% of AirSculpt Technologies shares are held by institutional investors. 44.6% of AirSculpt Technologies shares are held by insiders. Comparatively, 0.7% of Lumexa Imaging shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

AirSculpt Technologies presently has a consensus price target of $4.50, suggesting a potential downside of 7.79%. Lumexa Imaging has a consensus price target of $16.00, suggesting a potential upside of 42.10%. Given Lumexa Imaging's stronger consensus rating and higher possible upside, analysts plainly believe Lumexa Imaging is more favorable than AirSculpt Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AirSculpt Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, AirSculpt Technologies had 1 more articles in the media than Lumexa Imaging. MarketBeat recorded 5 mentions for AirSculpt Technologies and 4 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 0.46 beat AirSculpt Technologies' score of 0.40 indicating that Lumexa Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AirSculpt Technologies	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lumexa Imaging	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Lumexa Imaging beats AirSculpt Technologies on 11 of the 16 factors compared between the two stocks.

How does AirSculpt Technologies compare to Talkspace?

AirSculpt Technologies (NASDAQ:AIRS) and Talkspace (NASDAQ:TALK) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

Talkspace has higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AirSculpt Technologies	$151.82M	2.27	-$11.67M	-$0.17	N/A
Talkspace	$228.87M	3.81	$7.79M	$0.01	521.00

In the previous week, AirSculpt Technologies and AirSculpt Technologies both had 5 articles in the media. Talkspace's average media sentiment score of 1.50 beat AirSculpt Technologies' score of 0.40 indicating that Talkspace is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AirSculpt Technologies	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Talkspace	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

AirSculpt Technologies has a beta of 2.33, suggesting that its stock price is 133% more volatile than the broader market. Comparatively, Talkspace has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market.

AirSculpt Technologies currently has a consensus price target of $4.50, suggesting a potential downside of 7.79%. Talkspace has a consensus price target of $5.56, suggesting a potential upside of 6.77%. Given Talkspace's stronger consensus rating and higher possible upside, analysts plainly believe Talkspace is more favorable than AirSculpt Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AirSculpt Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Talkspace	1 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

91.5% of AirSculpt Technologies shares are held by institutional investors. Comparatively, 57.4% of Talkspace shares are held by institutional investors. 44.6% of AirSculpt Technologies shares are held by company insiders. Comparatively, 23.5% of Talkspace shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Talkspace has a net margin of 0.49% compared to AirSculpt Technologies' net margin of -7.39%. Talkspace's return on equity of 1.03% beat AirSculpt Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AirSculpt Technologies	-7.39%	-4.98%	-2.36%
Talkspace	0.49%	1.03%	0.88%

Summary

Talkspace beats AirSculpt Technologies on 12 of the 15 factors compared between the two stocks.

How does AirSculpt Technologies compare to Castle Biosciences?

Castle Biosciences (NASDAQ:CSTL) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

92.6% of Castle Biosciences shares are owned by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are owned by institutional investors. 6.1% of Castle Biosciences shares are owned by company insiders. Comparatively, 44.6% of AirSculpt Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Castle Biosciences has a net margin of -5.43% compared to AirSculpt Technologies' net margin of -7.39%. Castle Biosciences' return on equity of -4.15% beat AirSculpt Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Castle Biosciences	-5.43%	-4.15%	-3.45%
AirSculpt Technologies	-7.39%	-4.98%	-2.36%

Castle Biosciences has a beta of 0.98, indicating that its stock price is 2% less volatile than the broader market. Comparatively, AirSculpt Technologies has a beta of 2.33, indicating that its stock price is 133% more volatile than the broader market.

Castle Biosciences currently has a consensus price target of $42.00, suggesting a potential upside of 38.20%. AirSculpt Technologies has a consensus price target of $4.50, suggesting a potential downside of 7.79%. Given Castle Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe Castle Biosciences is more favorable than AirSculpt Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Castle Biosciences	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80
AirSculpt Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

AirSculpt Technologies has lower revenue, but higher earnings than Castle Biosciences. Castle Biosciences is trading at a lower price-to-earnings ratio than AirSculpt Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Castle Biosciences	$344.23M	2.68	-$24.16M	-$0.66	N/A
AirSculpt Technologies	$151.82M	2.27	-$11.67M	-$0.17	N/A

In the previous week, Castle Biosciences had 15 more articles in the media than AirSculpt Technologies. MarketBeat recorded 20 mentions for Castle Biosciences and 5 mentions for AirSculpt Technologies. Castle Biosciences' average media sentiment score of 0.46 beat AirSculpt Technologies' score of 0.40 indicating that Castle Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Castle Biosciences	8 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
AirSculpt Technologies	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Castle Biosciences beats AirSculpt Technologies on 11 of the 17 factors compared between the two stocks.

Get AirSculpt Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AIRS vs. The Competition

Export

Metric	AirSculpt Technologies	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$339.33M	$9.93B	$6.86B	$12.44B
Dividend Yield	N/A	2.54%	2.60%	10.03%
P/E Ratio	-28.70	25.38	280.72	24.99
Price / Sales	2.27	4.92	588.10	90.57
Price / Cash	269.59	26.44	28.64	34.82
Price / Book	3.49	5.22	11.02	6.21
Net Income	-$11.67M	$312.25M	$3.48B	$347.49M
7 Day Performance	4.72%	-0.95%	0.80%	1.29%
1 Month Performance	7.96%	-0.90%	-4.17%	-3.59%
1 Year Performance	-19.07%	24.98%	61.47%	18.38%

AirSculpt Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AIRS AirSculpt Technologies	0.8156 of 5 stars	$4.88 +1.5%	$4.50 -7.8%	-17.4%	$339.33M	$151.82M	N/A	240	News Coverage Upcoming Earnings
PSNL Personalis	2.3697 of 5 stars	$11.88 -0.8%	$14.25 +19.9%	+144.9%	$1.25B	$69.65M	N/A	400	Upcoming Earnings
OMDA Omada Health	3.0989 of 5 stars	$20.43 -0.7%	$24.33 +19.1%	+18.0%	$1.22B	$260.21M	N/A	849	Analyst Forecast
LMRI Lumexa Imaging	4.2291 of 5 stars	$10.97 -0.7%	$16.00 +45.9%	N/A	$1.06B	$267.73M	N/A	5,019
TALK Talkspace	3.3941 of 5 stars	$5.21 -0.2%	$5.56 +6.8%	+125.5%	$874.42M	$228.87M	521.52	500	Positive News Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AIRS) was last updated on 8/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AirSculpt Technologies (AIRS) Competitors

AIRS vs. PSNL, OMDA, LMRI, TALK, and CSTL

How does AirSculpt Technologies compare to Personalis?

Summary

How does AirSculpt Technologies compare to Omada Health?

Summary

How does AirSculpt Technologies compare to Lumexa Imaging?

Summary

How does AirSculpt Technologies compare to Talkspace?

Summary

How does AirSculpt Technologies compare to Castle Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIRS vs. The Competition

AirSculpt Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AirSculpt Technologies (AIRS) Competitors

AIRS vs. PSNL, OMDA, LMRI, TALK, and CSTL

How does AirSculpt Technologies compare to Personalis?

Does the media prefer AIRS or PSNL?

Which has stronger earnings and valuation, AIRS or PSNL?

Which has more risk and volatility, AIRS or PSNL?

Is AIRS or PSNL more profitable?

Do analysts recommend AIRS or PSNL?

Do institutionals & insiders believe in AIRS or PSNL?

Summary

How does AirSculpt Technologies compare to Omada Health?

Does the media refer more to AIRS or OMDA?

Which has more volatility & risk, AIRS or OMDA?

Do analysts recommend AIRS or OMDA?

Which has stronger valuation & earnings, AIRS or OMDA?

Is AIRS or OMDA more profitable?

Do insiders and institutionals have more ownership in AIRS or OMDA?

Summary

How does AirSculpt Technologies compare to Lumexa Imaging?

Which has higher earnings and valuation, AIRS or LMRI?

Is AIRS or LMRI more profitable?

Do institutionals & insiders have more ownership in AIRS or LMRI?

Do analysts recommend AIRS or LMRI?

Does the media prefer AIRS or LMRI?

Summary

How does AirSculpt Technologies compare to Talkspace?

Which has preferable valuation and earnings, AIRS or TALK?

Does the media prefer AIRS or TALK?

Which has more risk & volatility, AIRS or TALK?

Do analysts recommend AIRS or TALK?

Do institutionals and insiders have more ownership in AIRS or TALK?

Is AIRS or TALK more profitable?

Summary

How does AirSculpt Technologies compare to Castle Biosciences?

Do insiders and institutionals hold more shares of CSTL or AIRS?

Is CSTL or AIRS more profitable?

Which has more volatility and risk, CSTL or AIRS?

Do analysts rate CSTL or AIRS?

Which has better valuation and earnings, CSTL or AIRS?

Does the media favor CSTL or AIRS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIRS vs. The Competition

AirSculpt Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools